StockNews.com Begins Coverage on Arcadia Biosciences (NASDAQ:RKDA)

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report published on Sunday. The firm issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Price Performance

Arcadia Biosciences stock opened at $3.43 on Friday. The firm has a market capitalization of $4.68 million, a P/E ratio of -0.80 and a beta of 0.86. Arcadia Biosciences has a 1-year low of $1.85 and a 1-year high of $10.31. The company’s 50-day moving average is $4.27 and its 200 day moving average is $4.13.

Hedge Funds Weigh In On Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC bought a new stake in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned 0.90% of Arcadia Biosciences at the end of the most recent quarter. 17.73% of the stock is owned by institutional investors and hedge funds.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.